T2 Biosystems (NASDAQ:TTOO – Get Free Report) is set to announce its earnings results after the market closes on Thursday, November 14th. Individual that are interested in registering for the company’s earnings conference call can do so using this link.
T2 Biosystems Price Performance
Shares of TTOO stock opened at $0.52 on Wednesday. The company’s 50 day moving average is $1.71 and its 200 day moving average is $3.57. T2 Biosystems has a 52-week low of $0.51 and a 52-week high of $8.38.
Wall Street Analyst Weigh In
Several research firms have recently commented on TTOO. StockNews.com raised T2 Biosystems to a “sell” rating in a research report on Tuesday, July 30th. Canaccord Genuity Group boosted their target price on shares of T2 Biosystems from $3.00 to $5.00 and gave the stock a “hold” rating in a report on Tuesday, July 30th.
About T2 Biosystems
T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.
Further Reading
- Five stocks we like better than T2 Biosystems
- How to Invest in Blue Chip Stocks
- Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Is Tesla’s Valuation a Bubble or Backed by Real Growth?
- How Technical Indicators Can Help You Find Oversold Stocks
- Trucking Stocks Led the Pack Last Week: Can They Keep Rolling?
Receive News & Ratings for T2 Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for T2 Biosystems and related companies with MarketBeat.com's FREE daily email newsletter.
